References
- Munsat TL. Development of measurement techniques. Neurology 1996; 47(Suppl 2): S83–S85.
- Brooks BR. Clinical evaluation of ALS drugs. Neurology 1997; 48(Suppl 4): S23–S27.
- Jenkinson C, Swash M, Fitzpatrick R. The European Amyotrophic Lateral Sclerosis Health Profile Study. ALS-HPS Steering Group. J Neurol Sci 1998; 160(Suppl 1): S122–S126.
- Young CA, Tedman BM, Williams IR. Disease progression and perceptions of health in patients with motor neurone disease. J Neurol Sci 1995; 129(suppl): 50–53.
- Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997; 152(Suppl 1): S75–S79.
- Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30(6): 473–483.
- Simmons Z, Bremer BA, Robbins RA et al. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000; 55(3): 388–392.
- Robbins RA, Simmons Z, Bremer BA et al. Quality of life in ALS is maintained as physical function declines. Neurology 2001; 56(4): 442–444.
- Clarke S, Hickey A, O’Boyle C, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001; 10(2): 149–158.
- Jenkinson C, Fitzpatrick R, Swash M, Peto V. The ALS Health Profile Study: quality of life of amyotrophic lateral sclerosis patients and carers in Europe. J Neurol 2000; 247(11): 835– 840.
- Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res 2001; 10: 395–404.
- Jenkinson C, Hobart J, Chandola T et al. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 2002; 249: 178–183.
- Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999; 53(1): 46–50.
- Jenkinson C, Fitzpatrick R, Brennan CM et al. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 1999; 246(Suppl 3): III16–III21.
- Kazis LE, Anderson JJ, Meenan RF. Health status as a predictor of mortality in rheumatoid arthritis: a five-year study. J Rheumatol 1990; 17(5): 609–613.
- Waldron D, O’Boyle CA, Kearney M et al. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 1999; 17(11): 3603–3611.
- Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191(1–2): 103–109.